Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) vs Sonoma Pharmaceuticals, Inc. (SNOA)

A side-by-side comparison of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares and Sonoma Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares logo
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
$6M
$2.09HealthcareDelayed quote: Oct 6, 2026, 2:38 PM EDT
Sonoma Pharmaceuticals, Inc. logo
SNOA
Sonoma Pharmaceuticals, Inc.
$6M
$1.21HealthcareDelayed quote: Oct 6, 2026, 2:29 PM EDT

Total return — CUPR vs SNOA

growth of $100 · dividends reinvested · last 1y
CUPR -93.2% (-93.2%/yr)SNOA -35.1% (-35.1%/yr)SNOA compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002026$7$65
CUPR SNOA

CUPR vs SNOA: by the numbers

  • •SNOA is the larger company ($6M vs $6M market cap).
  • •Both run net losses; SNOA's is the smaller (-10.33% vs -9366.75% net margin).

Metrics side by side

Valuation

MetricCUPRSNOA
P/S ratioN/A0.26
P/B ratio1.430.88

Profitability

MetricCUPRSNOA
Gross margin-1.29%38.91%
Operating margin-9154.62%-6.41%
Net margin-9366.75%-10.33%
ROE-92.44%-34.33%
ROIC-84.15%-10.98%

Growth (annualized)

MetricCUPRSNOA
Revenue CAGR (5Y)N/A5.79%
Total return CAGR (5Y)N/A-59.29%

Go deeper

Full CUPR analysisFull SNOA analysisInteractive comparison tool

Dig into the metrics

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ROESonoma Pharmaceuticals ROECuprina Holdings (Cayman) Limited Class A Ordinary Shares operating marginSonoma Pharmaceuticals operating marginCuprina Holdings (Cayman) Limited Class A Ordinary Shares revenue growthSonoma Pharmaceuticals revenue growthCuprina Holdings (Cayman) Limited Class A Ordinary Shares free cash flowSonoma Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.